|
41
Million Americans have not been screened for
Colorectal Cancer (CRC)5
|
|
CRC is the #2
cancer killer in the U.S., second only to lung
cancer1
|
|
In 2003, it is
estimated there will be more than 147,500 new
cases and more than 57,000 people will die1
|
|
5% lifetime risk
for an American (men & women) to get CRC1
|
|
|
Approximately
1 in 17 men and 1 in 18 women will get CRC in
their lifetime1
|
|
Early stages of
CRC often have no symptoms1
|
|
|
Five-year survival
rate is 90% when detected early, compared to
only 8% when it is detected in a late stage1
|
|
|
Only 37% of colorectal
cancers are detected early in large part due
to low screening rates1
|
|
|
Screening every
year with Hemoccult® fecal occult
blood test (FOBT) can lead to the detection
and removal of premalignant polyps and reduce
the risk of getting CRC by at least 20%2
|
|
|
Screening every
year with Hemoccult FOBT can reduce deaths from
CRC by up to 33%3
|
|
Screening
every year with Hemoccult FOBT can detect more
than 90% of CRC cases in average risk individuals
(i.e., those who are age 50 and older and have
no symptoms)4 |
| |
| |
